Company Filing History:
Years Active: 1990-1994
Title: Innovations of Inventor Peter Stegmuller from Augsburg, Germany
Introduction
Peter Stegmuller is an innovative inventor based in Augsburg, Germany. With a remarkable portfolio of two patents, he has made significant contributions to the fields of biochemistry and medical diagnostics.
Latest Patents
Stegmuller's most recent patents reflect his expertise in the determination and stabilization of key biochemical substances. The first, titled "Method and Standard Solution for the Determination of Thyroxine," introduces a calibration standard solution that includes thyroxine-binding globulin (TBG) and either thyroxine or triiodothyronine, dissolved in a buffer solution. This innovative method can utilize both human and bovine TBG for the accurate measurement of thyroxine (T4) or triiodothyronine (T3) in serum samples.
The second patent, "Process for Stabilizing Kinase," presents a process that stabilizes creatine kinase through disulfide modification. This involves reacting creatine kinase in a specific sequence to enhance its stability, which is crucial for various biochemical applications.
Career Highlights
Peter Stegmuller is affiliated with Boehringer Mannheim GmbH, a renowned company known for its contributions to the medical diagnostics industry. Throughout his career, he has focused on developing innovative solutions that enhance diagnostic accuracy and reliability.
Collaborations
Peter has worked alongside notable colleagues, including Helmut Rehner and Knut Bartl. Their collaboration has fostered a dynamic environment for scientific innovation, allowing them to tackle complex challenges in biochemical research and applications.
Conclusion
Peter Stegmuller exemplifies the spirit of innovation in the field of biochemistry. His contributions, particularly in the form of his latest patents, not only advance scientific knowledge but also enhance practical medical diagnostics. As a key figure in this domain, Stegmuller continues to influence the landscape of biochemical innovations.